Navigation Links
Vion Pharmaceuticals Receives a Standard Review from the FDA for Its New Drug Application for Onrigin(TM)
Date:4/23/2009

ion Statement filed on March 23, 2009. Except in special circumstances in which a duty to update arises under law when prior disclosure becomes materially misleading in light of subsequent events, Vion does not intend to update any of these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

    COMPANY CONTACT: Vion Pharmaceuticals, Inc.
                     Alan Kessman, Chief Executive Officer
                     Howard B. Johnson, President & CFO
                     (203) 498-4210


'/>"/>
SOURCE Vion Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Valeant Pharmaceuticals to Announce 2009 First Quarter Results on May 5, 2009
2. Genesis Pharmaceuticals Changes its Name to Jiangbo Pharmaceuticals, Inc. to Reflect its Brand Name
3. Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results
4. Genesis Pharmaceuticals Announces the Launch of Three TCM Products
5. Celator(R) Pharmaceuticals Presents New Data on CPX-351 And CPX-1 at the American Association for Cancer Research
6. Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Oral Picoplatin Demonstrating Bioavailability
7. Par Pharmaceutical Enters Into Agreement With Reliant Pharmaceuticals to Settle Patent Litigation Over Rythmol(R) SR
8. AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents
9. Strativa Pharmaceuticals Provides Product Pipeline Update
10. ISTA Pharmaceuticals Announces Conference Call and Webcast of First Quarter 2009 Financial Results
11. Amylin Pharmaceuticals Reports First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Hill, South Carolina (PRWEB) October 30, 2014 ... muscle, and should be more vigorously exercised to help ... He recently authored the book ‘Dementia Express: Lose Your ... The book uses counterintuitive reasoning and sometimes conflicting attitudes ... obstacle course for the mind, a reader must decipher ...
(Date:10/30/2014)... -- Scientists who used stem cells to create miniature ... provide a new way to learn more about the ... used human pluripotent stem cells -- which can become ... grow the functional miniature stomachs, to study infection by ... ulcers and stomach cancer. The miniature stomachs offer ...
(Date:10/30/2014)... -- Americans, opinions about the Affordable Care Act are ... Democratic voters are strongly in favor of the ... three-quarters of Democrats want the next Congress to move ... implement the current law, while 44 percent want to ... voters, one-third want the law repealed, and 27 percent ...
(Date:10/29/2014)... Many of the women at first acted surprised. Some insisted ... why they had not used the study products assigned to ... that, as a likely consequence, did not find any of ... , The women were among 127 former VOICE participants who, ... to take part in in-depth interviews and/or focus group discussions ...
(Date:10/28/2014)... (October 27, 2014)—Although oral hormonal therapy is known ... with hormone receptor–positive tumors, about one-half of patients ... study by Columbia University Medical Center (CUMC) researchers ... inhibitors (the most common type of hormone therapy), ... counterparts, increased treatment adherence by 50 percent. , ...
Breaking Medicine News(10 mins):Health News:‘Dementia Express’ Offers Contradictory and Sometimes Reverse Thinking, All to Keep its Reader on Their Toes With an Active Mind. 2Health News:Voters' Views on Obamacare Split Along Party Lines 2Health News:Women who took part in VOICE speak up about why they didn't use HIV prevention products 2Health News:Women who took part in VOICE speak up about why they didn't use HIV prevention products 3Health News:Generic medications boost adherence to breast cancer therapy 2Health News:Generic medications boost adherence to breast cancer therapy 3
... of times our cells can divide is dictated by telomeres, ... how telomeres keep our chromosomes and by extension, our ... in the fields of both aging and cancer. Now, scientists ... on the structure and function of a crucial domain in ...
... and the UCLA Henry Samueli School of Engineering and ... of Homeland Security,s Science and Technology Directorate to help ... in the field. The UCLA team will work ... on the agency,s PHASER (Physiological Health Assessment System for ...
... Reporter , WEDNESDAY, Sept. 15 (HealthDay News) -- Fresh on the ... study shows that men who have a low prostate-specific antigen (PSA) ... men with a high PSA reading -- 2 nanograms per milliliter ... risk of developing the disease, the researchers added. "If ...
... risk of cardiovascular disease, stroke, high blood pressure, or ... International Journal of Data Mining, Modelling and Management . ... network computer program to analyze patient data and spot ... for an individual. Khanna Nehemiah of the Anna ...
... HealthDay Reporter , TUESDAY Sept. 14 (HealthDay News) -- A ... has sickened a handful of people in North America, with ... officials said Tuesday. But the bacterium -- designated ... of another bacterium that,s been present in the United States ...
... by Indiana University and Columbia University researchers found no ... mental illness or substance abuse problems despite a greater ... illnesses. The study, published online Sept. 15 ... vexing questions about the effectiveness of campaigns designed to ...
Cached Medicine News:Health News:Protein clamps tight to telomeres to help prevent aging...and support cancer 2Health News:Protein clamps tight to telomeres to help prevent aging...and support cancer 3Health News:UCLA selected by Homeland Security to help establish guidelines for firefighter health and safety 2Health News:Men With Low PSA at 60 Might Not Need Further Screening 2Health News:Men With Low PSA at 60 Might Not Need Further Screening 3Health News:Fuzzy thinking could spot heart disease risk 2Health News:New Drug-Resistant 'Superbug' Reaches U.S. Shores 2Health News:New Drug-Resistant 'Superbug' Reaches U.S. Shores 3Health News:Study: Mental illness stigma entrenched in American culture; new strategies needed 2Health News:Study: Mental illness stigma entrenched in American culture; new strategies needed 3
(Date:10/30/2014)... October 30, 2014 , Extensively ... cow milk   Cow milk protein allergy (CMPA) is the ... childhood. Until now, it has been managed by eliminating ... been shown that it is possible to help build ... number of children during the first year of life ...
(Date:10/30/2014)... nebulizer is a medical device used for the treatment ... converts liquid medication into mist or aerosol. Thus, the ... patient when inhaled through the mouth or a face ... devices powered by electric current and rechargeable batteries. Factors ... fibrosis and growing number of geriatric population worldwide support ...
(Date:10/30/2014)... Oct. 29, 2014   ViaDerma, Inc. ... bringing new products to market, is committed to ... has developed an innovative, patent-pending dual carrier transdermal ... of pharmaceutical active ingredients to penetrate the skin ... therapy. The transdermal delivery method also overcomes microbial ...
Breaking Medicine Technology:Experts Present Latest Research at Allergy Day 2Experts Present Latest Research at Allergy Day 3Nebulizers Market (Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 2Nebulizers Market (Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 3ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 2ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 3
... 1b study planned for mid 2008 with Phase 2 development ... to begin late in 2008 or in early ... NUVO ) today announced positive results from the Phase 1,proof-of-concept ... offset of anticoagulation after,a single bolus dose with a favorable safety ...
... Erythematosus ... ... (Nasdaq: RIGL ) announced today that its lead product,candidate, R788, ... reported in a recently published,study of the drug candidate. R788 (fostamatinib ...
Cached Medicine Technology:Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172 2Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172 3Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172 4Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies 2Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies 3Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies 4
An enzyme linked immunoassay (ELISA) for the detection and semiquantitation of IgG, IgA or IgM anticardiolipin antibodies, as an aid in assessing the risk of thrombosis in individuals with Systemic L...
... Research Grade Microscope Camera from ImagingPlanet ... imaging technology that delivers increased image ... an affordable price. Document, Archive ... 3.3 mega-pixel digital microscope camera designed ...
The ImagingPlanet 70 mm surgical microscope video adapter: Superior optical quality and precise engineering make this 70 mm focal length adapter an excellent decision for use with your Leica surgica...
The ImagingPlanet 55 mm surgical microscope video adapter: superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Zeiss surgical ...
Medicine Products: